Results for tag: "Allogeneic Human Chondrocyte Therapy"

Allogeneic Human Chondrocyte Therapy (AHCT) is a type of musculoskeletal disorder drug used to treat cartilage damage. It involves the transplantation of healthy chondrocytes, which are cells that make up cartilage, from a donor to the patient. The donor cells are grown in a laboratory and then injected into the damaged area. AHCT is used to treat cartilage damage caused by osteoarthritis, trauma, and other conditions. It can help reduce pain and improve joint function. AHCT is a relatively new treatment option and is still being studied. It is not yet widely available, but is becoming more common in some countries. It is generally considered to be a safe and effective treatment option for cartilage damage. Some companies in the AHCT market include Vericel Corporation, CartiHeal, and Orthocell. Show Less Read more